Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma
Open Access
- 16 September 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 32 (7), 673-679
- https://doi.org/10.1038/sj.bmt.1704214
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphomaBone Marrow Transplantation, 1999
- A Prognostic Score for Advanced Hodgkin's DiseaseThe New England Journal of Medicine, 1998
- Autotransplantation for relapsed or refractory Hodgkin’s disease: long-term follow-up and analysis of prognostic factorsBone Marrow Transplantation, 1998
- Progressive disease after ABMT for Hodgkin’s diseaseBone Marrow Transplantation, 1997
- Durability of remission after ABMT for NHL: the importance of the 2-year evaluation pointBone Marrow Transplantation, 1997
- The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic GroupsBritish Journal of Haematology, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1987
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958